« Previous AbstractSelective olfactory exposure alters social and plant odor preferences of immature hamsters    Next AbstractOptimisation of derivatisation procedures for the determination of delta13C values of amino acids by gas chromatography/combustion/isotope ratio mass spectrometry »

J Infect

Title:		"The potential of a portable, point-of-care electronic nose to diagnose tuberculosis"
Author(s):		Coronel Teixeira R; Rodriguez M; Jimenez de Romero N; Bruins M; Gomez R; Yntema JB; Chaparro Abente G; Gerritsen JW; Wiegerinck W; Perez Bejerano D; Magis-Escurra C;
Address:		"Instituto Nacional de Enfermedades Respiratorias y del Ambiente (INERAM), Asuncion, Paraguay. Instituto Nacional de Enfermedades Respiratorias y del Ambiente (INERAM), Asuncion, Paraguay; Laboratorio Central de Salud Publica (LCSP), Asuncion, Paraguay. The eNose Company, Zutphen, The Netherlands. Radboud University Medical Centre - Dekkerswald, Nijmegen, Groesbeek, The Netherlands. Radboud University, Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen, Nijmegen, The Netherlands; Big4Data, Nijmegen, The Netherlands. Radboud University Medical Centre - Dekkerswald, Nijmegen, Groesbeek, The Netherlands. Electronic address: cecile.magis-escurra@RadboudUMC.nl"
Journal Title:		J Infect
Year:		2017
Volume:		20170810
Issue:		5
Page Number:		441 - 447
DOI:		10.1016/j.jinf.2017.08.003
ISSN/ISBN:		1532-2742 (Electronic) 0163-4453 (Linking)
Abstract:		"INTRODUCTION: Tuberculosis (TB) is the leading cause of death due to an infectious disease worldwide. Especially in low-income countries, new diagnostic techniques that are accessible, inexpensive and easy-to-use, are needed to shorten transmission time and initiate treatment earlier. OBJECTIVE: We conducted a study with a handheld, point-of-care electronic nose (eNose) device to diagnose TB through exhaled breath. SETTING: This study includes a total of 110 patients and visitors of an expert centre of respiratory diseases in Asuncion, Paraguay. TB diagnosis was established by culture of Mycobacterium tuberculosis complex and compared with the eNose results in two phases. RESULTS: The calibration phase, including only culture confirmed TB cases versus healthy people, demonstrated a sensitivity and specificity of 91% and 93% respectively. The confirmation phase, including all participants, showed a sensitivity of 88% and a specificity of 92%. The eNose showed high acceptance rate among participants, and was easy to operate. CONCLUSION: The eNose resulted in a powerful technique to differentiate between healthy people and TB patients. Its comfort, speed and usability promise great potential in vulnerable groups, in remote areas and hospital settings to triage patients with suspicion of TB"
Keywords:		"Adult *Electronic Nose Female Humans Male Paraguay *Point-of-Care Systems Tuberculosis, Pulmonary/*diagnosis Breath smell prints Exhaled breath Tuberculosis Volatile organic compounds (VOC's);"
Notes:		"MedlineCoronel Teixeira, Rosarito Rodriguez, Mabel Jimenez de Romero, Nilda Bruins, Marcel Gomez, Roscio Yntema, Jan Bart Chaparro Abente, Gilberto Gerritsen, Jan Willem Wiegerinck, Wim Perez Bejerano, Domingo Magis-Escurra, Cecile eng Clinical Trial Research Support, Non-U.S. Gov't England 2017/08/15 J Infect. 2017 Nov; 75(5):441-447. doi: 10.1016/j.jinf.2017.08.003. Epub 2017 Aug 10"